These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17536156)

  • 1. Collaborative study for the calibration of HCV RNA, HBV DNA and HIV RNA reference preparations against the relative international standards.
    Pisani G; Marino F; Cristiano K; Bisso GM; Mele C; Luciani F; Wirz M; Gentili G;
    Ann Ist Super Sanita; 2007; 43(1):69-76. PubMed ID: 17536156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collaborative study for the calibration of a new Italian HCV RNA reference preparation against the international standard.
    Gentili G; Cristiano K; Pisani G; Bisso GM; Miceli M; Wirz M;
    Ann Ist Super Sanita; 2003; 39(2):183-7. PubMed ID: 14587216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and quantitation of HBV DNA in the WHO International Standard for HIV-1 RNA (NIBSC code: 97/656).
    Shyamala V; Cottrell J; Arcangel P; Madriaga D; Linnen J; Phelps B; Chien D
    J Virol Methods; 2004 Jun; 118(1):69-72. PubMed ID: 15158070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection.
    Koppelman MH; Sjerps MC; Reesink HW; Cuypers HT
    Vox Sang; 2005 Nov; 89(4):193-200. PubMed ID: 16262751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External quality assessment for the detection of blood-borne viruses in plasma by nucleic acid amplification technology: the first human immunodeficiency virus and hepatitis B virus studies (HIV EQA/1 and HBV EQA/1) and the fifth hepatitis C virus study (HCV EQA/5).
    Pisani G; Cristiano K; Saldanha J; Wirz M; Bisso GM; Mele C; Gentili G;
    Vox Sang; 2004 Aug; 87(2):91-5. PubMed ID: 15355499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels.
    Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; van Drimmelen H; David B; Lelie N; De Micco P
    Transfusion; 2009 Feb; 49(2):301-10. PubMed ID: 19389212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. World Health Organization collaborative study to calibrate the 3rd International Standard for Hepatitis C virus RNA nucleic acid amplification technology (NAT)-based assays.
    Baylis SA; Heath AB;
    Vox Sang; 2011 May; 100(4):409-17. PubMed ID: 21488880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
    Nübling CM; Unkelbach U; Chudy M; Seitz R
    Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.
    Koppelman MH; Assal A; Chudy M; Torres P; de Villaescusa RG; Reesink HW; Lelie PN; Cuypers HT
    Transfusion; 2005 Aug; 45(8):1258-66. PubMed ID: 16078910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardization: a progress report.
    Saldanha J
    Biologicals; 1999 Dec; 27(4):285-9. PubMed ID: 10686054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-laboratory comparison of qualitative and quantitative detection of hepatitis C (HCV) virus RNA in diagnostic virology: a multicentre study (MS) in Italy.
    Mancini C; Pisani G; Azzi A; Luisa Zerbini M; Gentili G; Mario Bisso G;
    J Clin Virol; 2004 Aug; 30(4):313-9. PubMed ID: 15163420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA.
    Margaritis AR; Brown SM; Seed CR; Kiely P; D'Agostino B; Keller AJ
    Transfusion; 2007 Oct; 47(10):1783-93. PubMed ID: 17880602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An international collaborative study to establish the 2nd World Health Organization International Standard for hepatitis B virus DNA nucleic acid amplification technology-based assays.
    Baylis SA; Heath AB; Chudy M; Pisani G; Klotz A; Kerby S; Gerlich W
    Vox Sang; 2008 May; 94(4):358-62. PubMed ID: 18266781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External quality assessment for the detection of HCV RNA, HIV RNA and HBV DNA in plasma by nucleic acid amplification technology: a novel approach.
    Pisani G; Marino F; Cristiano K; Bisso GM; Mele C; Luciani F; Wirz M; Gentili G;
    Vox Sang; 2008 Jul; 95(1):8-12. PubMed ID: 18380770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an automated high-volume extraction method for viral nucleic acids in comparison to a manual procedure with preceding enrichment.
    Hourfar MK; Schmidt M; Seifried E; Roth WK
    Vox Sang; 2005 Aug; 89(2):71-6. PubMed ID: 16101686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European multi-centre validation study of NucliSens Extractor in combination with HCV Amplicor 2.0 assay for HCV-NAT screening of plasma pools.
    Cuypers HT; van Dijk R; Viret JF; Schottstedt V; Lankinen M; Da Silva Cardoso M; Lelie PN
    Biologicals; 1999 Dec; 27(4):303-14. PubMed ID: 10686057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of low HBV-DNA levels by nucleic acid amplification test (NAT) in blood donors.
    Dettori S; Candido A; Kondili LA; Chionne P; Taffon S; Genovese D; Iudicone P; Miceli M; Rapicetta M
    J Infect; 2009 Aug; 59(2):128-33. PubMed ID: 19586663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. World Health Organization collaborative study to establish a replacement WHO international standard for hepatitis C virus RNA nucleic acid amplification technology assays.
    Saldanha J; Heath A; Aberham C; Albrecht J; Gentili G; Gessner M; Pisani G
    Vox Sang; 2005 Apr; 88(3):202-4. PubMed ID: 15787732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201.
    Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; David B; De Micco P
    Transfusion; 2009 Feb; 49(2):289-300. PubMed ID: 19000230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.